Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.1134 EUR
−68.45 M EUR
666.10 M EUR
332.03 M
About Cresco Labs, Inc.
Sector
Industry
CEO
Charles Bachtell
Website
Headquarters
Chicago
Founded
1990
ISIN
CA22587M1068
FIGI
BBG00PXPR0X6
Cresco Labs Inc. engages in cultivating medical grade cannabis, manufacturing medical products derived from cannabis cultivation, and distributing such products to medical or adult use consumers. It focuses on regulatory compliance while working to develop condition-specific strains of cannabis and non-invasive delivery methods. The company was founded by Charles Bachtel, Joseph Caltabiano, Dominic Sergi, Rob Sampson, and Brian McCormack on July 6, 1990 and is headquartered in Chicago, IL.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where 6CQ is featured.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange Cresco Labs, Inc. stocks are traded under the ticker 6CQ.
We've gathered analysts' opinions on Cresco Labs, Inc. future price: according to them, 6CQ price has a max estimate of 2.01 EUR and a min estimate of 0.94 EUR. Watch 6CQ chart and read a more detailed Cresco Labs, Inc. stock forecast: see what analysts think of Cresco Labs, Inc. and suggest that you do with its stocks.
Yes, you can track Cresco Labs, Inc. financials in yearly and quarterly reports right on TradingView.
Cresco Labs, Inc. is going to release the next earnings report on Nov 7, 2025. Keep track of upcoming events with our Earnings Calendar.
6CQ earnings for the last quarter are −0.03 EUR per share, whereas the estimation was −0.03 EUR resulting in a −11.70% surprise. The estimated earnings for the next quarter are −0.02 EUR per share. See more details about Cresco Labs, Inc. earnings.
Cresco Labs, Inc. revenue for the last quarter amounts to 138.90 M EUR, despite the estimated figure of 138.90 M EUR. In the next quarter, revenue is expected to reach 141.06 M EUR.
6CQ net income for the last quarter is −14.09 M EUR, while the quarter before that showed −13.30 M EUR of net income which accounts for −5.97% change. Track more Cresco Labs, Inc. financial stats to get the full picture.
No, 6CQ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 7, 2025, the company has 2.9 K employees. See our rating of the largest employees — is Cresco Labs, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Cresco Labs, Inc. EBITDA is 129.73 M EUR, and current EBITDA margin is 24.35%. See more stats in Cresco Labs, Inc. financial statements.
Like other stocks, 6CQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cresco Labs, Inc. stock right from TradingView charts — choose your broker and connect to your account.